Trials / Completed
CompletedNCT00688012
Safety Study of SPC3649 in Healthy Men
A Placebo-controlled, Double-blind, Randomized, Single Dose, Dose Escalating Trial in Healthy Men to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPC3649
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 64 (planned)
- Sponsor
- Santaris Pharma A/S · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A placebo-controlled, double-blind, randomized, single dose, dose escalating trial in healthy men to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of SPC3649.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SPC3649 |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2009-05-01
- Completion
- 2009-05-01
- First posted
- 2008-06-02
- Last updated
- 2009-09-18
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00688012. Inclusion in this directory is not an endorsement.